Revolution Medicines, Inc. Warrant

RVMDW: SECURITIES AND EXCHANGE COMMISSION

Revolution Medicines, Inc. Warrant (RVMDW) just filed. RVMDW to acquire platform ($2.7M) (8-K 2026-09-01). Exhibit numbers: Deal $2.7M. Why it matters: Transaction value about $2.7M

Those exhibit numbers sit next to the income-statement cache: Net income was -$766.4M. The RVMDW filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Revolution Medicines, Inc. Warrant said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

8-KEX-99.11.012.03

SECURITIES AND EXCHANGE COMMISSION

RVMDW to acquire platform ($2.7M)

Deal
$2.7M

Why it matters

  • Transaction value about $2.7M
Source on EDGAR

0

10-K

0

10-Q

3

8-K

0

Form 4

Recent filings

8-K1.012.03

SECURITIES AND EXCHANGE COMMISSION

RVMDW to acquire platform ($2.7M)

EDGAR
8-K8.01

8-K exhibit

EDGAR
8-K5.025.07

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all RVMDW filings.

Frequently asked questions

What did RVMDW just say?

RVMDW to acquire platform ($2.7M)

Where are RVMDW SEC filings?

3 cached filings are on this page. EDGAR remains the official archive (CIK 0001628171).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.